Profile

Founded in 2024, DIA Labs is a biotechnology and medical device R&D company based in Ontario, Canada. It develops innovative, patient-centric technologies to improve healthcare outcomes, including its flagship product, AirSense – a Class II wearable device for continuous asthma monitoring. Backed by $450,000 in non-dilutive funding, it integrates engineering, clinical research, and data science to deliver real-world solutions. The DIA Labs team collaborates with academic and clinical partners and is currently pursuing FDA clearance for AirSense.

DIA Labs Canada logo

Website

Dialabscanada.com

Contact


Event details

Date: October 5 - 8, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

14 in total